DANIEL MUSHER to Cost-Benefit Analysis
This is a "connection" page, showing publications DANIEL MUSHER has written about Cost-Benefit Analysis.
Connection Strength
0.078
-
Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clin Infect Dis. 2011 Apr 15; 52(8):1079; author reply 1079-80.
Score: 0.078
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.